Latest Pharmaceutical industry regulation News

FILE - This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. Investors are driving shares of drug developer BioMarin down by a third after U.S. regulators rejected its potentially game-changing gene therapy for hemophilia A patients. The FDA's rejection late Tuesday, Aug. 18, 2020, means BioMarin will have to complete an ongoing late-stage patient study.  (AP Photo/Jacquelyn Martin, File)

FDA blocks much-anticipated BioMarin hemophilia gene therapy

Aug. 19, 2020 3:08 PM EDT

FAIRLESS HILLS, PA (AP) — Investors fled drug developer BioMarin in droves on Wednesday, driving shares down by a third after U.S. regulators rejected the company’s potentially game-changing hemophilia A gene therapy over concerns it might not really be a one-and-done lifetime treatment. The U.S....

FILE - In this Wednesday, March 4, 2020 file photo, Jon Ossoff speaks to the media and supporters after he qualified to run in the Senate race against Republican Sen. David Perdue in Atlanta. The Democratic Senate candidate is in isolation as is his wife, who contracted COVID-19, Ossoff confirmed Saturday, July 25, 2020. (Bob Andres/Atlanta Journal-Constitution via AP)

The Latest: Ga. Democratic Senate candidate's wife has virus

Jul. 25, 2020 6:22 PM EDT

ATLANTA -- Georgia Democratic Senate candidate Jon Ossoff says he's in isolation with his wife, who contracted COVID-19. The 33-year-old candidate said his wife, Dr. Alisha Kramer, has mild coronavirus symptoms and that he’s showing symptoms, too. He said he was tested Saturday and is awaiting results...